Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001047469-04-012993
Filing Date
2004-04-22
Accepted
2004-04-22 09:02:05
Documents
5
Period of Report
2003-12-31

Document Format Files

Seq Description Document Type Size
1 10-K/A a2133671z10-ka.htm 10-K/A 1591624
3 EXHIBIT 23.1 a2130498zex-23_1.txt EX-23.1 909
4 EXHIBIT 31.1 a2130498zex-31_1.txt EX-31.1 3057
5 EXHIBIT 31.2 a2130498zex-31_2.txt EX-31.2 3090
6 EXHIBIT 32.1 a2130498zex-32_1.txt EX-32.1 2461
  Complete submission text file 0001047469-04-012993.txt   1603151
Mailing Address 51 SAWYER ROAD SUITE 200 WALTHAM MA 02453
Business Address 51 SAWYER ROAD SUITE 200 WALTHAM MA 02453 7816473900
INVERNESS MEDICAL INNOVATIONS INC (Filer) CIK: 0001145460 (see all company filings)

EIN.: 043565120 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-16789 | Film No.: 04746865
SIC: 2835 In Vitro & In Vivo Diagnostic Substances